Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2010
11/17/2010CN101888988A Process for the preparation of pharmaceutical i nterm ediates
11/17/2010CN101885732A Heterocyclic-sulfur fused naphthalenetetracarboxylic acid diimide derivatives, preparation method and application thereof
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101885730A Compound for resisting thrombus
11/17/2010CN101168544B Technique for preparing olanzapine
11/16/2010US7834176 Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
11/16/2010US7834026 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; hydroxamic acid moiety
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/11/2010WO2010128685A1 Alpha helix mimetics and methods relating thereto
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286171 Phenylacetamide derivative
11/11/2010US20100286166 Compositions for the treatment of hyperphenylalaninemia
11/11/2010US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/11/2010US20100286127 Antitumor agent
11/11/2010US20100285149 Novel tetrahydropyridothiophenes
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/10/2010EP2248840A1 Condensed polycyclic compound, condensed polycyclic polymer and organic thin film containing the compound or the polymer
11/10/2010EP2248818A1 Organic semiconductor material
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP1618113B1 Novel crystalline polymorphs of clopidogrel
11/10/2010CN1874843B Novel multicomponent oxidation catalyst and process for producing epoxy compound therewith
11/10/2010CN101880287A Intermediate compounds for thiophane nucleoside analogues and preparation method thereof
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101255169B Prasugrel salt and preparation method thereof
11/10/2010CN101033232B Method of preparing olanzapine crystal system I
11/09/2010US7829700 Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
11/09/2010CA2412899C Medicinal preparations for treating sex hormone-dependent diseases
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010CA2760048A1 Therapeutic agent for motor disorders
11/03/2010EP2246354A1 Thieno[3,2-d]pyrimidine derivative useful as PI3K inhibitor
11/03/2010EP2245014A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
11/03/2010EP2006291B1 Fused polycyclic polymer, organic thin film containing the polymer and organic thin film transistor comprising the organic thin film
11/03/2010EP1781667B1 Benzothienopyridines for use as inhibitors of eg5 kinesin
11/03/2010EP1513845B2 A process for the preparation of olanzapine and an intermediate therefor
11/03/2010CN101878211A Aminothiazole derivatives
11/03/2010CN101878201A Fused indane compound
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825118 4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives; can be covalently bonded to Bruton's tyrosine kinase; autoimmune diseases, lymphoma, leukemia; antiproliferative, anticarcinogenic and antiinflammatory agents
11/02/2010CA2545527C Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
11/02/2010CA2462799C Pyrimidine derivatives
10/2010
10/28/2010WO2010124108A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124102A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010123079A1 Electrically conductive polyrotaxane
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010121487A1 Preparation and use of novel antibiotic, anticancer compounds and derivatives thereof
10/28/2010WO2009121946A3 Process for the preparation of optically enriched clopidogrel
10/28/2010US20100273847 Desferrioxamine conjugates, derivatives and analogues
10/28/2010US20100273830 Novel insecticides
10/28/2010US20100273815 Thieno[2,3-d]-pyrimidin-4(3h)-one compounds with antifungal properties and process thereof
10/28/2010US20100273792 Macrocyclic indoles as hepatitis c virus inhibitors
10/28/2010US20100273791 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
10/28/2010US20100273784 Fused ring heterocycles as potassium channel modulators
10/28/2010US20100273779 Pyridazinone Derivatives
10/28/2010US20100273199 Methods and Compositions
10/28/2010CA2759793A1 Preparation and application of the new antibacterial and anticancer compounds and their derivatives
10/28/2010CA2759655A1 Heteroaryl compounds and uses thereof
10/28/2010CA2759621A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759547A1 Azetidinyl diamides as monoacylglycerol lipase inhibitors
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2242736A1 Process for the preparation of pharmaceutical i nterm ediates
10/27/2010CN101870864A Application of thiospirolactone in intracellular hypochloric acid detection
10/27/2010CN101870703A Linked disulfide propyl porphyrin and metal complex, preparation method and application thereof
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/26/2010US7820666 Tetrahydrotriazolopyrazine derivatives and uses thereof
10/26/2010US7820658 such as 2-Amino-4-phenyl-thieno[2,3-d]pyrimidine-6-carboxylic acid ethylamide; veterinary medicine; anticancer agents
10/26/2010US7820648 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
10/26/2010US7820631 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
10/26/2010CA2457053C Preventive agent/remedial agent for constipation predominant ibs
10/21/2010WO2010120987A1 Ring fused, ureidoaryl- and carbamoylaryl-bridged morpholino-pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010120013A1 Novel rhodamine derivative and hypochlorous acid detecting sensor comprising same
10/21/2010WO2010084499A3 Bicyclic heterocyclic spiro compounds
10/21/2010WO2010076813A4 Thienopyridines as pharmacologically active agents
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267796 Therapeutic agent for irritable bowel syndrome
10/21/2010US20100267695 Fused indane compound
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100266507 Luminescent compounds
10/20/2010EP2241569A1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses
10/20/2010EP2240494A1 Thieno-pyridine derivatives as mek inhibitors
10/20/2010EP2240493A2 Antibiotic tetrahydro-beta-carboline derivatives
10/20/2010EP2240446A2 Carbazole-containing materials in phosphorescent light emitting diodes
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP1768984B1 Thienopyrimidines useful as aurora kinase inhibitors
10/20/2010CN101868464A Thienopyrimidiene derivatives as PI3k inhibitors
10/20/2010CN101864006A Thioxanthone photoinitiator containing cyclic acetal and preparation method thereof
10/20/2010CN101863903A 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof
10/20/2010CN101863902A Preparation method and application of 2-substituted phenyl-2-(4,5,6,7-thiophane [3,2-c] pyridine-5(4H)-group) acetic acid (substituted alkyl alcohol) ester
10/20/2010CN101863901A 2-(substituted phenyl)-2-(4,5,6,7-thiophane[3,2-c] pyridine-5(4H)-group)-N-substitute-acetamide as well as preparation method and application thereof
10/20/2010CN101863900A Novel nitric oxide donating thienopyridine derivative and preparation method and application thereof
10/20/2010CN101863899A Method for improving resolution yield of clopidogrel camphorsulfonate
10/20/2010CN101863898A Thieno pyridinone derivative containing piperazidine and preparation method and applications thereof
10/20/2010CN101529609B Field-effect transistor
10/19/2010US7816519 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 214